Coe Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-86,587
Closed -$1.37M 109
2016
Q3
$1.37M Buy
86,587
+18,900
+28% +$333K 0.44% 87
2016
Q2
$829K Hold
67,687
0.29% 106
2016
Q1
$456K Sell
67,687
-2,313
-3% -$14.8K 0.15% 159
2015
Q4
$646K Buy
+70,000
New +$651K 0.26% 118
2015
Q1
Sell
-20,685
Closed -$568K 222
2014
Q4
$568K Sell
20,685
-14,000
-40% -$341K 0.18% 151
2014
Q3
$672K Sell
34,685
-10,000
-22% -$183K 0.25% 123
2014
Q2
$761K Sell
44,685
-13,349
-23% -$184K 0.27% 117
2014
Q1
$822K Sell
58,034
-120,844
-68% -$1.63M 0.24% 134
2013
Q4
$2.1M Buy
178,878
+96,798
+118% +$1.11M 0.73% 39
2013
Q3
$969K Buy
82,080
+32,080
+64% +$412K 0.65% 43
2013
Q2
$695K Buy
+50,000
New +$543K 0.27% 116

Other funds holding EXAS

Coe Capital Management's EXAS Position: Q4 2016 in Review

Coe Capital Management sold out of Exact Sciences (EXAS) in Q4 2016, closing a stake of 86,587 shares — an estimated $1.37M sold.

Coe Capital Management first reported a position in EXAS in Q2 2013 and held it in 11 quarters. The position peaked at $2.1M in Q4 2013. 222 funds tracked by Wall St. Rank hold EXAS as of Q4 2016.

  • Coe Capital Management reported no remaining Exact Sciences position as of Q4 2016 after selling out during the quarter.
  • Coe Capital Management sold 86,587 Exact Sciences shares in Q4 2016, an estimated $1.37M.
  • Coe Capital Management first reported a position in Exact Sciences in Q2 2013 and held it in 11 quarters.
  • Coe Capital Management's Exact Sciences position peaked at $2.1M in Q4 2013.
  • 222 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2016.

Based on Coe Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.